 |
|
Advances in the Treatment of Spinal Metastasis: Commentary on “Spinal Metastases and the Evolving Role of Molecular Targeted Therapy, Chemotherapy, and Immunotherapy”
Stephen Bergin, Khoi D. Than
Neurospine. 2022;19(4):994-995. Published online 2022 Dec 31 DOI: https://doi.org/10.14245/ns.2245044.522
|
|
Citations to this article as recorded by
 Transpedicular Corpectomy in Minimally Invasive Surgery for Metastatic Spinal Cord Compression: A Single-Center Series
Gervith Reyes Soto, Daniel Vega Moreno, Monica Serrano-Murillo, Carlos Castillo-Rangel, Alberto Gonzalez-Aguilar, José Rodrigo Meré Gómez , Pablo Isaac Garcìa Fuentes, Bernardo Cacho Diaz, Manuel de Jesus Encarnacion Ramirez, Vladimir Nikolenko, Tshiunza
Cureus.2024;[Epub] CrossRef Incorporation of whole-body metabolic tumor burden into current prognostic models for non-small cell lung cancer patients with spine metastasis
Yoontae Hong, Yeon-koo Kang, Eun Bi Park, Min-Sung Kim, Yunhee Choi, Siyoung Lee, Chang-Hyun Lee, Jun-Hoe Kim, Miso Kim, Jin Chul Paeng, Chi Heon Kim
The Spine Journal.2024;[Epub] CrossRef Commentary on “The Role and Clinical Outcomes of Endoscopic Spine Surgery of Treating Spinal Metastases; Outcomes of 29 Cases From 8 Countries”
Wongthawat Liawrungrueang, Vit Kotheeranurak
Neurospine.2023; 20(2): 620. CrossRef
|